Free Trial

Jade Biosciences (JBIO) Competitors

Jade Biosciences logo
$8.28 -0.05 (-0.60%)
As of 07/25/2025 04:00 PM Eastern

JBIO vs. MIRA, GBIO, ENLV, SCYX, NNVC, QTTB, RANI, FBLG, NRSN, and CLSD

Should you be buying Jade Biosciences stock or one of its competitors? The main competitors of Jade Biosciences include MIRA Pharmaceuticals (MIRA), Generation Bio (GBIO), Enlivex Therapeutics (ENLV), SCYNEXIS (SCYX), NanoViricides (NNVC), Q32 Bio (QTTB), Rani Therapeutics (RANI), FibroBiologics (FBLG), NeuroSense Therapeutics (NRSN), and Clearside Biomedical (CLSD). These companies are all part of the "pharmaceutical products" industry.

Jade Biosciences vs. Its Competitors

Jade Biosciences (NASDAQ:JBIO) and MIRA Pharmaceuticals (NASDAQ:MIRA) are both small-cap medical companies, but which is the superior business? We will contrast the two businesses based on the strength of their analyst recommendations, profitability, risk, institutional ownership, valuation, dividends, media sentiment and earnings.

MIRA Pharmaceuticals is trading at a lower price-to-earnings ratio than Jade Biosciences, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Jade BiosciencesN/AN/A-$69.63M-$59.65-0.14
MIRA PharmaceuticalsN/AN/A-$7.85M-$0.51-3.39

In the previous week, Jade Biosciences and Jade Biosciences both had 1 articles in the media. Jade Biosciences' average media sentiment score of 1.89 beat MIRA Pharmaceuticals' score of 1.87 indicating that Jade Biosciences is being referred to more favorably in the media.

Company Overall Sentiment
Jade Biosciences Very Positive
MIRA Pharmaceuticals Very Positive

35.2% of MIRA Pharmaceuticals shares are held by institutional investors. 24.9% of Jade Biosciences shares are held by insiders. Comparatively, 6.7% of MIRA Pharmaceuticals shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.

Jade Biosciences has a beta of 1.06, meaning that its share price is 6% more volatile than the S&P 500. Comparatively, MIRA Pharmaceuticals has a beta of 1.72, meaning that its share price is 72% more volatile than the S&P 500.

Jade Biosciences currently has a consensus price target of $15.00, suggesting a potential upside of 81.16%. MIRA Pharmaceuticals has a consensus price target of $14.00, suggesting a potential upside of 709.25%. Given MIRA Pharmaceuticals' stronger consensus rating and higher probable upside, analysts plainly believe MIRA Pharmaceuticals is more favorable than Jade Biosciences.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Jade Biosciences
0 Sell rating(s)
0 Hold rating(s)
2 Buy rating(s)
0 Strong Buy rating(s)
3.00
MIRA Pharmaceuticals
0 Sell rating(s)
0 Hold rating(s)
2 Buy rating(s)
1 Strong Buy rating(s)
3.33

Jade Biosciences' return on equity of -60.01% beat MIRA Pharmaceuticals' return on equity.

Company Net Margins Return on Equity Return on Assets
Jade BiosciencesN/A -60.01% -54.32%
MIRA Pharmaceuticals N/A -341.08%-272.93%

Summary

MIRA Pharmaceuticals beats Jade Biosciences on 7 of the 12 factors compared between the two stocks.

Get Jade Biosciences News Delivered to You Automatically

Sign up to receive the latest news and ratings for JBIO and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding JBIO and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

JBIO vs. The Competition

MetricJade BiosciencesMED IndustryMedical SectorNASDAQ Exchange
Market Cap$7M$3.05B$5.70B$9.50B
Dividend YieldN/A2.37%4.58%4.00%
P/E Ratio-0.1421.3228.3920.08
Price / SalesN/A285.38431.7689.31
Price / CashN/A42.7636.2258.56
Price / Book0.098.378.675.88
Net Income-$69.63M-$55.19M$3.25B$258.89M
7 Day Performance-12.57%5.86%4.25%3.71%
1 Month Performance-10.49%17.29%10.51%11.72%
1 Year PerformanceN/A4.39%35.68%18.01%

Jade Biosciences Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
JBIO
Jade Biosciences
2.3989 of 5 stars
$8.28
-0.6%
$15.00
+81.2%
N/A$7MN/A-0.1420Positive News
MIRA
MIRA Pharmaceuticals
2.5944 of 5 stars
$1.75
+4.2%
$14.00
+700.0%
-43.1%$28.42MN/A-3.432
GBIO
Generation Bio
4.0251 of 5 stars
$4.27
+1.4%
$80.00
+1,773.5%
-86.5%$28.22M$24.56M-3.95150Analyst Downgrade
Stock Split
High Trading Volume
ENLV
Enlivex Therapeutics
2.7974 of 5 stars
$1.18
-0.8%
$10.00
+747.5%
-19.3%$28.15MN/A-1.7970News Coverage
Analyst Forecast
Gap Up
SCYX
SCYNEXIS
0.8915 of 5 stars
$0.71
-0.2%
N/A-65.0%$27.76M$3.75M-1.2760Positive News
NNVC
NanoViricides
0.3568 of 5 stars
$1.70
+0.6%
N/A-24.0%$27.32MN/A-2.3620
QTTB
Q32 Bio
2.4766 of 5 stars
$2.24
+2.8%
$12.17
+443.2%
-94.2%$26.59M$1.16M-0.4539News Coverage
RANI
Rani Therapeutics
2.4906 of 5 stars
$0.44
+4.8%
$7.33
+1,566.7%
-81.5%$26.55M$1.03M-0.44110Positive News
Gap Up
FBLG
FibroBiologics
3.816 of 5 stars
$0.67
+0.4%
$13.00
+1,840.0%
-85.8%$26.48MN/A-3.1910Positive News
Gap Up
NRSN
NeuroSense Therapeutics
2.7053 of 5 stars
$1.93
-0.1%
$14.00
+626.1%
+150.6%$26.38MN/A-3.5710
CLSD
Clearside Biomedical
2.2879 of 5 stars
$0.35
+3.7%
$4.20
+1,095.2%
-56.0%$26.34M$1.66M-0.8630High Trading Volume

Related Companies and Tools


This page (NASDAQ:JBIO) was last updated on 7/26/2025 by MarketBeat.com Staff
From Our Partners